Interventional cardiology is a medical specialty well known for embracing promising new device technologies, and as a result, the field has progressed over the years well beyond its initial focus on c
Cook Medical Inc. ’s Zilver PTX became the first drug-eluting stent to gain FDA approval for peripheral arterial disease earlier this month, marking an important milestone for the field, but how th
by Mary Thompson "Where do we go from here" is a question that physicians and manufacturers active in the interventional cardiology space have asked, and successfully answered, time and again over the